AMN Healthcare Services Inc

20.63-0.10 (-0.48%)

Oct 29, 4:00:02 PM EDT · NYSE · AMN · USD

Upcoming Earnings

Report date

Nov 6, 2025 (in 7 days)

Key Stats

Market Cap

790.63M

P/E (TTM)

Basic EPS (TTM)

-7.79

Dividend Yield

Recent Filings

8-K

AMN refinances 2027 notes with new debt

10/6/25Oct 6, 2025

AMN Healthcare's subsidiary issued $400 million in 6.5% senior notes due 2031 on October 6, 2025, while amending its credit agreement to extend the revolving facility's maturity to October 6, 2030, shrink it from $750 million to $450 million, and ease leverage covenants to 5.25x through March 2027. These moves will fund the redemption of $500 million in 2027 notes on October 22, 2025, using $100 million in new borrowings, note proceeds, and cash. This refinances shorter-term debt at a higher rate, but stretches maturities and loosens terms amid market pressures. Debt swap extends runway.

10-Q

Q2 FY2025 results

8/8/25Aug 8, 2025

AMN Healthcare's Q2 revenue fell 11% year-over-year to $658.2 million, driven by a 14% drop in nurse and allied solutions amid lower traveler volumes and visa delays, while physician solutions eased 6% on softer locum tenens demand yet higher rates per day filled. Gross margins slipped to 29.8% from 31.0%, pressured by rising provider pay, but operating losses stemmed mainly from a $109.5 million goodwill impairment in physician solutions and $18.3 million long-lived asset write-down in revenue cycle—net loss widened to $116.2 million, or $(3.02) diluted EPS, versus $16.2 million profit last year. Cash from operations held steady at $171.2 million year-to-date, funding $141.4 million in debt paydown to leave $70.0 million drawn on the $750.0 million revolver; free cash flow reached $151.4 million after $19.8 million capex. On July 1, 2025, AMN sold its Smart Square software for $65.3 million cash plus a $10.0 million note due 2027. Yet competition in staffing intensifies pricing risks.

8-K

AMN Q2 revenue drops 11%

8/7/25Aug 7, 2025

AMN Healthcare reported Q2 2025 revenue of $658 million, down 11% year-over-year, with adjusted EBITDA of $58.3 million and a GAAP net loss of $116 million driven by $128 million in non-cash impairment charges. The allied staffing unit outperformed projections, while travel nursing fell 25% amid policy uncertainty slowing client decisions. In July, AMN sold Smart Square for $75 million, cutting annualized revenue by $17 million but forging a tech partnership. Q3 guidance projects $610-$625 million revenue, down 9-11% year-over-year. Strong cash flow reduced debt by $80 million.

10-Q

Q1 FY2025 results

5/9/25May 9, 2025

AMN Healthcare's Q1 revenue fell 16% year-over-year to $689.5M, driven by a 20% drop in nurse and allied solutions to $413.3M amid lower traveler volumes, though labor disruption services surged $39M. Gross profit slid 23% to $198.1M with margins contracting to 28.7% from 31.4%, reflecting higher clinician pay packages, while operating income shrank to $12.5M from $39.9M. Diluted EPS turned negative at $(0.03), consistent with 38,312k shares and no anti-dilution. Cash from operations climbed to $92.7M, yielding $82.7M free cash flow (derived) after $10.0M capex; revolver drawdown to $150M left $579.6M available, backed by $55.8M cash. Net loss exceeded operating profit due to $12.3M interest. Declining demand for contingent labor persists as a key risk.

8-K

AMN Q1 revenue falls 16%

5/8/25May 8, 2025

AMN Healthcare reported Q1 2025 revenue of $690 million, down 16% year-over-year, with a GAAP net loss of $1 million but adjusted EPS of $0.45. Gross margins dipped to 28.7%, yet SG&A discipline drove operating leverage amid normalizing industry conditions. Locum tenens bookings improved sequentially. Q2 guidance projects $645-660 million revenue, down 11-13% year-over-year. Clients watch tariffs closely.

About

AMN Healthcare Services, Inc. provides technology-enabled healthcare workforce solutions and staffing services to acute and sub-acute care hospitals, and other healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. The Nurse and Allied Solutions segment offers travel nurse staffing, labor disruption staffing, local staffing, international nurse permanent placement, allied staffing, crisis nurse staffing for critical staffing and rapid response nursing, and allied health professionals, such as skilled nursing facilities, rehabilitation clinics, schools, and pharmacies. This segment also provides allied health professionals, such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists; and solutions for schools, including teletherapy platform, Televate, and qualified school speech-language pathologists, psychologists, nurses, social workers, and other care providers. The Physician and Leadership Solutions segment offers locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement solutions. The Technology and Workforce Solutions segment offers language services, vendor management systems, workforce optimization, and outsourced solutions. The company offers its services under the brands, including AMN Healthcare, Nursefinders, O'Grady Peyton International, Connetics, Medical Search International, DRW Healthcare Staffing, and B.E. Smith. AMN Healthcare Services, Inc. was founded in 1985 and is based in Dallas, Texas.

CEO

Ms. Caroline Sullivan Grace

IPO

11/13/2001

Website

https://www.amnhealthcare.com

Employees

2,968

Sector

Healthcare

Industry

Medical Care Facilities